1215485-03-2

Basic information

• Product Name: 3,4-diaminopyrrolidinyl-1-carboxylic acid tert-butyl ester
• Synonyms: 3,4-diaminopyrrolidinyl-1-carboxylic acid tert-butyl ester
• CAS NO: 1215485-03-2
• Molecular Weight: 201.269
• Mol File: 1215485-03-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3,4-diaminopyrrolidinyl-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-diaminopyrrolidinyl-1-carboxylic acid tert-butyl ester(1215485-03-2)
• EPA Substance Registry System: 3,4-diaminopyrrolidinyl-1-carboxylic acid tert-butyl ester(1215485-03-2)

Safety Data

• Hazardous Substances Data: 1215485-03-2(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 190141-99-2 [trans-]-3-amino-4-hydroxy-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester 
• 203434-45-1 (±)-tert-butyl 3-azido-4-hydroxypyrrolidine-1-carboxylate 
• 114214-49-2 1-tert-butoxycarbonyl-3,4-epoxypyrrolidine 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 

Relevant articles and documents

JAK inhibitor compound and application thereof

The invention relates to a JAK inhibitor compound and application thereof. Specifically, the invention discloses a compound shown as a formula (G), or an isotope labeled compound, or an optical isomer, a geometrical isomer, a tautomer or an isomer mixture of the compound, or a pharmaceutically acceptable salt of the compound, or a prodrug of the compound, or a metabolite of the compound. The invention also relates to the medical application of the compound.

Pyrrole imidazole ring derivative and medical use thereof wherein the compound represented by the general formula (I) has excellent inhibitory effect on and selectivity of dipeptidyl peptidase IV(DPP-IV)

The present invention relates to a pyrrole imidazole ring derivative and medical use thereof, more particularly a pyrrole imidazole ring derivative represented by the general formula (I) or stereoisomers thereof, pharmaceutically acceptable salts thereof, prodrugs, pharmaceutical compositions containing the derivative, and pharmaceutical applications for the preparation of dipeptidyl peptidase IV(DPP-IV) inhibitors, wherein the definitions of all substitution groups in general formula (I) are the same as those defined in the specification.